Average versus highest intraocular pressure analyses in glaucoma clinical trials.
نویسندگان
چکیده
PURPOSE To evaluate methods which account for both eyes as a single, independent variable in glaucoma clinical trials. METHODS A review of clinical trial articles published between January 1995 and April 2011 evaluating currently used topical glaucoma medications. RESULTS This analysis included 17 articles with 36 treatment arms of which 14 were prostaglandins, 13 β-blockers, 6 topical carbonic anhydrase inhibitors and 3 α-agonists. Twenty-four articles used average intraocular pressure (IOP) analysis, 12 used the highest IOP analysis and none utilized the randomized eye method. At untreated baseline, there was a difference in the IOP between average IOP and highest baseline IOP analyses at 8 a.m. (p = 0.001) and for the diurnal curve (p = 0.02) as well as specifically for β-blockers (p = 0.002) at 8 a.m. and β-blockers for the diurnal curve (p = 0.01). CONCLUSIONS This study suggests that the highest IOP analysis method generally provides slightly higher IOPs at baseline than the average IOP analysis method.
منابع مشابه
Intraocular Pressure Measurements by Three Different Tonometers in Children with Aphakic Glaucoma and a Thick Cornea
Background: To evaluate the agreement in intraocular pressure (IOP) measurements by Ocular Response Analyzer (ORA) and Tono-Pen XL (TXL) with the Goldmann Applanation Tonometer (GAT) and to examine corneal biomechanical properties in aphakic glaucoma patients with a central corneal thickness (CCT) >600 µ. Methods: Thirty-six eyes of aphakic glaucoma patients (group 1) and 40 eyes of normal chil...
متن کاملWhat is the Real Cause of Glaucoma?
Introduction: The term glaucoma refers to a group of diseases that have a characteristic optic neuropathy with associated visual field loss in common. Intraocular pressure has been considered to be the only causal factor for glaucoma and the only factor that can be manipulated to alter the course of the disease. But considering high intraocular pressure as the only factor responsible for glauco...
متن کاملThe placebo effect in early-phase glaucoma clinical trials.
PURPOSE To analyze the extent and prevalence of the placebo effect in prior early-phase glaucoma clinical studies. METHODS Articles were evaluated on phase I and II trials of glaucoma medicines that became commercially available after 1977 with a placebo arm that involved glaucoma patients. RESULTS We included 23 studies with 23 treatment arms with a total of 1703 patients in articles evalu...
متن کاملComparison of intraocular pressure measurement between rebound, non-contact and Goldmann applanation tonometry in treated glaucoma patients.
BACKGROUND To compare the intraocular pressure readings obtained with the iCare rebound tonometer and the 7CR non-contact tonometer with those measured by Goldmann applanation tonometry in treated glaucoma patients. DESIGN A prospective, cross-sectional study was conducted in a private tertiary glaucoma clinic. PARTICIPANTS OR SAMPLES One hundred nine (54 males : 55 females) patients includ...
متن کاملUpper limits of intraocular pressure in glaucoma clinical trials.
The parallel, randomized, double-masked, activecontrolled trial is generally thought to be the most rigorous and unbiased design to adequately compare two glaucoma medicines. Important to this design is the intraocular pressure entry criteria. The lower limit of intraocular pressure is usually set at least >21 mmHg to help assure the study population has the appropriate diagnosis (ocular hypert...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Ophthalmic research
دوره 49 1 شماره
صفحات -
تاریخ انتشار 2013